The brainstem pathologies of Parkinson's disease and dementia with lewy bodies

Brain Pathology

Volumn 25, Issue 2, 2015, Pages 121-135

  Seidel, Kay ^a   Mahlke, Josefine ^a   Siswanto, Sonny ^a   Krüger, Reijko ^b   Heinsen, Helmut ^c   Auburger, Georg ^a   Bouzrou, Mohamed ^a   Grinberg, Lea T ^d,e   Wicht, Helmut ^a   Korf, Horst Werner ^a   Den Dunnen, Wilfred ^f   Rüb, Udo ^a  

^a GOETHE UNIVERSITY   (Germany)

^b UNIVERSITY OF TÜBINGEN   (Germany)

^c UNIVERSITY OF WÜRZBURG   (Germany)

^d UNIVERSITY OF CALIFORNIA   (United States)

^e UNIVERSITY OF SÃO PAULO   (Brazil)

^f UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

Author keywords

alpha synuclein; brainstem; dementia with Lewy bodies; Parkinson's disease; prion like disease

Indexed keywords

ALPHA SYNUCLEIN;

ABDUCENS NUCLEUS; ADULT; AGED; ARCUATE NUCLEUS; ARTICLE; BALANCE IMPAIRMENT; BRAIN STEM; COILED BODY; CONTROLLED STUDY; CRANIAL NERVE NUCLEUS; CUNEATE NUCLEUS; DIFFUSE LEWY BODY DISEASE; DORSAL MOTOR VAGAL NUCLEUS; DORSAL RAPHE NUCLEUS; EYE MOVEMENT DISORDER; FACIAL NERVE NUCLEUS; FEMALE; FIBER TRACT; GAIT DISORDER; GIGANTOCELLULAR RETICULAR NUCLEUS; GRACILE NUCLEUS; HUMAN; HUMAN TISSUE; HYPOGLOSSAL NUCLEUS; INFERIOR OLIVE; INTERPOSITUS NUCLEUS; INTRA AXONAL TRANSPORT; LATERAL RETICULAR NUCLEUS; LATERAL VESTIBULAR NUCLEUS; LEWY BODY; LEWY NEURITE; LOCUS CERULEUS; MALE; MEDIAL VESTIBULAR NUCLEUS; MEDULLA OBLONGATA; MEDULLARY NUCLEUS; MESENCEPHALON; MIDDLE AGED; NERVE FIBER; NERVE FIBER TRANSPORT; NEURITE; NEUROPATHOLOGY; OLIGODENDROGLIA; PARABRACHIAL NUCLEUS; PARKINSON DISEASE; PEDUNCULOPONTINE TEGMENTAL NUCLEUS; PERIAQUEDUCTAL GRAY MATTER; PONS; PONS RETICULAR FORMATION; PONTINE NUCLEUS; POSTURAL REFLEX; PRECEREBELLAR BRAINSTEM NUCLEUS; PREMOTOR OCULOMOTOR NUCLEUS; PREPOSITUS HYPOGLOSSAL; RAPHE NUCLEUS; REFLEX; RETICULAR FORMATION; SOLITARY TRACT NUCLEUS; SUBSTANTIA NIGRA; SUPERIOR VESTIBULAR NUCLEUS; TRIGEMINAL NUCLEUS; VAGUS NERVE NUCLEUS; VENTRAL TEGMENTUM; VESTIBULAR BRAINSTEM NUCLEUS; VESTIBULAR NUCLEUS; METABOLISM; NERVE CELL; PATHOLOGY; VERY ELDERLY;

AGED; AGED, 80 AND OVER; ALPHA-SYNUCLEIN; BRAIN STEM; COILED BODIES; FEMALE; HUMANS; LEWY BODIES; LEWY BODY DISEASE; MALE; MIDDLE AGED; NEURONS; OLIGODENDROGLIA; PARKINSON DISEASE;

EID: 84922663952     PISSN: 10156305     EISSN: 17503639     Source Type: Journal    
DOI: 10.1111/bpa.12168     Document Type: Article

References (75)

1. Ahmed Z, Asi YT, Sailer A, Lees AJ, Houlden H, Revesz T, Holton JL, (2012) The neuropathology, pathophysiology and genetics of multiple system atrophy. Neuropathol Appl Neurobiol 38: 4-24.
2. Angot E, Steiner JA, Hansen C, Li JY, Brundin P, (2010) Are synucleinopathies prion-like disorders? Lancet Neurol 9: 1128-1138.
3. Barmack NH, (2003) Central vestibular system: vestibular nuclei and posterior cerebellum. Brain Res Bull 60: 511-541.
4. Benarroch EE, (2013) Pedunculopontine nucleus: functional organization and clinical implications. Neurology 80: 1148-1155.
5. Benarroch EE, Schmeichel AM, Sandroni P, Low PA, Parisi JE, (2006) Involvement of vagal autonomic nuclei in multiple system atrophy and Lewy body disease. Neurology 66: 378-383.
6. Braak H, Del Tredici K, Rüb U, de Vos RA, Jansen Steur EN, Braak E, (2003) Staging of brain pathology related to sporadic Parkinson's disease. Neurobiol Aging 24: 197-211.
7. Braak H, Rüb U, Del Tredici K, (2003) Involvement of precerebellar nuclei in multiple system atrophy. Neuropathol Appl Neurobiol 29: 60-76.
8. Braak H, Rüb U, Gai WP, Del Tredici K, (2003) Idiopathic Parkinson's disease: possible routes by which vulnerable neuronal types may be subject to neuroinvasion by an unknown pathogen. J Neural Transm 110: 517-536.
9. Brundin P, Melki R, Kopito R, (2010) Prion-like transmission of protein aggregates in neurodegenerative diseases. Nat Rev Mol Cell Biol 11: 301-307.
10. Burke RE, Dauer WT, Vonsattel JP, (2008) A critical evaluation of the Braak staging scheme for Parkinson's disease. Ann Neurol 64: 485-491.
11. Calne DB, Snow BJ, Lee C, (1992) Criteria for diagnosing Parkinson's disease. Ann Neurol 32: S125-S127.
12. Chaudhuri KR, Healy DG, Schapira AH, (2006) Non-motor symptoms of Parkinson's disease: diagnosis and management. Lancet Neurol 5: 235-245.
13. Costanzo M, Zurzolo C, (2013) The cell biology of prion-like spread of protein aggregates: mechanisms and implication in neurodegeneration. Biochem J 452: 1-17.
14. De Vos KJ, Grierson AJ, Ackerley S, Miller CC, (2008) Role of axonal transport in neurodegenerative diseases. Annu Rev Neurosci 31: 151-173.
15. Dickson DW, Braak H, Duda JE, Duyckaerts C, Gasser T, Halliday GM, et al (2009) Neuropathological assessment of Parkinson's disease: refining the diagnostic criteria. Lancet Neurol 8: 1150-1157.
16. Eggertson DE, Sima AA, (1986) Dementia with cerebral Lewy bodies. A mesocortical dopaminergic defect? Arch Neurol 43: 524-527.
17. Fellner L, Jellinger KA, Wenning GK, Stefanova N, (2011) Glial dysfunction in the pathogenesis of alpha-synucleinopathies: emerging concepts. Acta Neuropathol 121: 675-693.
18. Fellner L, Stefanova N, (2013) The role of glia in alpha-synucleinopathies. Mol Neurobiol 47: 575-586.
19. Gelb DJ, Oliver E, Gilman S, (1999) Diagnostic criteria for Parkinson disease. Arch Neurol 56: 33-39.
20. George S, Rey NL, Reichenbach N, Steiner JA, Brundin P, (2013) Alpha-synuclein: the long distance runner. Brain Pathol 23: 350-357.
21. German DC, Manaye K, Smith WK, Woodward DJ, Saper CB, (1989) Midbrain dopaminergic cell loss in Parkinson's disease: computer visualization. Ann Neurol 26: 507-514.
22. Gerrits NM, (1990) Vestibular nuclear complex. In: The Human Central Nervous System., G Paxinos, (ed.), pp. 863-888. Academic Press: San Diego.
23. Ghez C, (1991) Posture. In: Principles of Neural Science., ER Kandel, JH Schwartz, TM Jessell, (eds), pp. 626-646. Elsevier: New York.
24. Gibb WR, Esiri MM, Lees AJ, (1987) Clinical and pathological features of diffuse cortical Lewy body disease (Lewy body dementia). Brain 110: 1131-1153.
25. Gibb WR, Lees AJ, (1991) Anatomy, pigmentation, ventral and dorsal subpopulations of the substantia nigra, and differential cell death in Parkinson's disease. J Neurol Neurosurg Psychiatry 54: 388-396.
26. Goedert M, Clavaguera F, Tolnay M, (2010) The propagation of prion-like protein inclusions in neurodegenerative diseases. Trends Neurosci 33: 317-325.
27. Goto S, Hirano A, (1991) Catecholaminergic neurons in the parabrachial nucleus of normal individuals and patients with idiopathic Parkinson's disease. Ann Neurol 30: 192-196.
28. Grinberg LT, Rüb U, Alho AT, Heinsen H, (2010) Brainstem pathology and non-motor symptoms in PD. J Neurol Sci 289: 81-88.
29. Grinberg LT, Rüb U, Heinsen H, (2011) Brainstem: neglected locus in neurodegenerative diseases. Front Neurol 2: 42.
30. Halliday GM, Gai WP, Blessing WW, Geffen LB, (1990) Substance P-containing neurons in the pontomesencephalic tegmentum of the human brain. Neuroscience 39: 81-96.
31. Hansen C, Li JY, (2012) Beyond alpha-synuclein transfer: pathology propagation in Parkinson's disease. Trends Mol Med 18: 248-255.
32. Irizarry MC, Growdon W, Gomez-Isla T, Newell K, George JM, Clayton DF, Hyman BT, (1998) Nigral and cortical Lewy bodies and dystrophic nigral neurites in Parkinson's disease and cortical Lewy body disease contain alpha-synuclein immunoreactivity. J Neuropathol Exp Neurol 57: 334-337.
33. Jellinger KA, (2003) Neuropathological spectrum of synucleinopathies. Mov Disord 18 (Suppl. 6): S2-S12.
34. Jellinger KA, (2008) A critical reappraisal of current staging of Lewy-related pathology in human brain. Acta Neuropathol 116: 1-16.
35. Jellinger KA, (2009) A critical evaluation of current staging of alpha-synuclein pathology in Lewy body disorders. Biochim Biophys Acta 1792: 730-740.
36. Jucker M, Walker LC, (2011) Pathogenic protein seeding in Alzheimer disease and other neurodegenerative disorders. Ann Neurol 70: 532-540.
37. Kalf JG, de Swart BJ, Bloem BR, Munneke M, (2012) Prevalence of oropharyngeal dysphagia in Parkinson's disease: a meta-analysis. Parkinsonism Relat Disord 18: 311-315.
38. Krüger R, Müller T, Riess O, (2000) Involvement of alpha-synuclein in Parkinson's disease and other neurodegenerative disorders. J Neural Transm 107: 31-40.
39. Langston JW, (2006) The Parkinson's complex: parkinsonism is just the tip of the iceberg. Ann Neurol 59: 591-596.
40. de Lau LM, Breteler MM, (2006) Epidemiology of Parkinson's disease. Lancet Neurol 5: 525-535.
41. Leigh RJ, Zee DS, (2006) The Neurology of Eye Movements. Elsevier: Philadelphia.
42. Leopold NA, Kagel MC, (1983) Swallowing, ingestion and dysphagia: a reappraisal. Arch Phys Med Rehabil 64: 371-373.
43. Litvan I, Bhatia KP, Burn DJ, Goetz CG, Lang AE, McKeith I, et al (2003) Movement disorders society scientific issues committee report: SIC task force appraisal of clinical diagnostic criteria for Parkinsonian disorders. Mov Disord 18: 467-486.
44. McKeith IG, Dickson DW, Lowe J, Emre M, O'Brien JT, Feldman H, et al (2005) Diagnosis and management of dementia with Lewy bodies: third report of the DLB Consortium. Neurology 65: 1863-1872.
45. McKeith IG, Mosimann UP, (2004) Dementia with Lewy bodies and Parkinson's disease. Parkinsonism Relat Disord 10 (Suppl. 1): S15-S18.
46. McRitchie DA, Cartwright HR, Halliday GM, (1997) Specific A10 dopaminergic nuclei in the midbrain degenerate in Parkinson's disease. Exp Neurol 144: 202-213.
47. Mori F, Piao YS, Hayashi S, Fujiwara H, Hasegawa M, Yoshimoto M, et al (2003) Alpha-synuclein accumulates in Purkinje cells in Lewy body disease but not in multiple system atrophy. J Neuropathol Exp Neurol 62: 812-819.
48. Murray AM, Weihmueller FB, Marshall JF, Hurtig HI, Gottleib GL, Joyce JN, (1995) Damage to dopamine systems differs between Parkinson's disease and Alzheimer's disease with parkinsonism. Ann Neurol 37: 300-312.
49. Obeso JA, Marin C, Rodriguez-Oroz C, Blesa J, Benitez-Temino B, Mena-Segovia J, et al (2008) The basal ganglia in Parkinson's disease: current concepts and unexplained observations. Ann Neurol 64 (Suppl. 2): S30-S46.
50. Paulus W, Jellinger K, (1991) The neuropathologic basis of different clinical subgroups of Parkinson's disease. J Neuropathol Exp Neurol 50: 743-755.
51. Pfeiffer RF, (2003) Gastrointestinal dysfunction in Parkinson's disease. Lancet Neurol 2: 107-116.
52. Piao YS, Mori F, Hayashi S, Tanji K, Yoshimoto M, Kakita A, et al (2003) Alpha-synuclein pathology affecting Bergmann glia of the cerebellum in patients with alpha-synucleinopathies. Acta Neuropathol 105: 403-409.
53. Roy S, Zhang B, Lee VM, Trojanowski JQ, (2005) Axonal transport defects: a common theme in neurodegenerative diseases. Acta Neuropathol 109: 5-13.
54. Rüb U, Brunt ER, Petrasch-Parwez E, Schöls L, Theegarten D, Auburger G, et al (2006) Degeneration of ingestion-related brainstem nuclei in spinocerebellar ataxia type 2, 3, 6 and 7. Neuropathol Appl Neurobiol 32: 635-649.
55. Rüb U, Brunt ER, de Vos RA, Del Turco D, Del Tredici K, Gierga K, et al (2004) Degeneration of the central vestibular system in spinocerebellar ataxia type 3 (SCA3) patients and its possible clinical significance. Neuropathol Appl Neurobiol 30: 402-414.
56. Rüb U, Gierga K, Brunt ER, de Vos RA, Bauer M, Schöls L, et al (2005) Spinocerebellar ataxias types 2 and 3: degeneration of the pre-cerebellar nuclei isolates the three phylogenetically defined regions of the cerebellum. J Neural Transm 112: 1523-1545.
57. Rüb U, Heinsen H, Brunt ER, Landwehrmeyer B, den Dunnen WF, Gierga K, Deller T, (2009) The human premotor oculomotor brainstem system-can it help to understand oculomotor symptoms in Huntington's disease? Neuropathol Appl Neurobiol 35: 4-15.
58. Rüb U, Jen JC, Braak H, Deller T, (2008) Functional neuroanatomy of the human premotor oculomotor brainstem nuclei: insights from postmortem and advanced in vivo imaging studies. Exp Brain Res 187: 167-180.
59. Sacino AN, Giasson BI, (2012) Does a prion-like mechanism play a major role in the apparent spread of alpha-synuclein pathology? Alzheimers Res Ther 4: 48.
60. Schmeichel AM, Buchhalter LC, Low PA, Parisi JE, Boeve BW, Sandroni P, Benarroch EE, (2008) Mesopontine cholinergic neuron involvement in Lewy body dementia and multiple system atrophy. Neurology 70: 368-373.
61. Seidel K, Schöls L, Nuber S, Petrasch-Parwez E, Gierga K, Wszolek Z, et al (2010) First appraisal of brain pathology owing to A30P mutant alpha-synuclein. Ann Neurol 67: 684-689.
62. Smithson KG, MacVicar BA, Hatton GI, (1983) Polyethylene glycol embedding: a technique compatible with immunocytochemistry, enzyme histochemistry, histofluorescence and intracellular staining. J Neurosci Methods 7: 27-41.
63. Steiner JA, Angot E, Brundin P, (2011) A deadly spread: cellular mechanisms of alpha-synuclein transfer. Cell Death Differ 18: 1425-1433.
64. Terada S, Ishizu H, Haraguchi T, Takehisa Y, Tanabe Y, Kawai K, Kuroda S, (2000) Tau-negative astrocytic star-like inclusions and coiled bodies in dementia with Lewy bodies. Acta Neuropathol 100: 464-468.
65. Vaugoyeau M, Viel S, Assaiante C, Amblard B, Azulay JP, (2007) Impaired vertical postural control and proprioceptive integration deficits in Parkinson's disease. Neuroscience 146: 852-863.
66. Visanji NP, Brooks PL, Hazrati LN, Lang AE, (2013) The prion hypothesis in Parkinson's disease: Braak to the future. Acta Neuropathol Commun 1: 2.
67. Vitale C, Marcelli V, Furia T, Santangelo G, Cozzolino A, Longo K, et al (2011) Vestibular impairment and adaptive postural imbalance in parkinsonian patients with lateral trunk flexion. Mov Disord 26: 1458-1463.
68. Wakabayashi K, Hayashi S, Yoshimoto M, Kudo H, Takahashi H, (2000) NACP/alpha-synuclein-positive filamentous inclusions in astrocytes and oligodendrocytes of Parkinson's disease brains. Acta Neuropathol 99: 14-20.
69. Walker Z, Stevens T, (2002) Dementia with Lewy bodies: clinical characteristics and diagnostic criteria. J Geriatr Psychiatry Neurol 15: 188-194.
70. Weisman D, McKeith I, (2007) Dementia with Lewy bodies. Semin Neurol 27: 42-47.
71. Wenning GK, Colosimo C, Geser F, Poewe W, (2004) Multiple system atrophy. Lancet Neurol 3: 93-103.
72. Wenning GK, Stefanova N, Jellinger KA, Poewe W, Schlossmacher MG, (2008) Multiple system atrophy: a primary oligodendrogliopathy. Ann Neurol 64: 239-246.
73. White OB, Saint-Cyr JA, Tomlinson RD, Sharpe JA, (1983) Ocular motor deficits in Parkinson's disease. II. Control of the saccadic and smooth pursuit systems. Brain 106 (Pt 3): 571-587.
74. Wu T, Hallett M, (2013) The cerebellum in Parkinson's disease. Brain 136: 696-709.
75. Zweig RM, Jankel WR, Hedreen JC, Mayeux R, Price DL, (1989) The pedunculopontine nucleus in Parkinson's disease. Ann Neurol 26: 41-46.